Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA) - PubMed (original) (raw)
Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA)
S Mölstad et al. Scand J Infect Dis. 1999.
Abstract
In order to reduce inappropriate use of antibiotics and to counteract the increase in antimicrobial resistance in community-acquired and nosocomial infections, a national project was initiated in Sweden in 1994: the Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance. In the first years the project focused on inappropriate prescribing of antibiotics to children with respiratory tract infections and on the surveillance of resistance in pneumococci. Statistics on antibiotic sales on a national and county level and for different age-groups were studied. Between 1993 and 1997 antibiotic prescribing was reduced by 22%, from 16.3 to 13.0 defined daily doses (DDD) per 1000 inhabitants/d. The reduction was most pronounced for children, 0-6-y-old, from 15.7 to 9.7 DDD/1000 children/d. Macrolides and amoxicillin/co-amoxyclav decreased most. There were large variations in antibiotic sales in different counties, and a decrease was also noted in counties starting from a low level. In the county with the highest sales in 1993, antibiotic prescribing to children was reduced by 40%. The national frequency of penicillin-non-susceptible pneumococci (MIC > or =0.1 mg/l) has not increased during the 1990s and the increasing incidence in southern Sweden seems to have been curtailed. During the period that the project has been running, a major change in the use of antibiotics, especially for pre-school children, has been achieved.
Similar articles
- Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme.
Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, Lundborg CS, Söderström A, Torell E, Cars O. Mölstad S, et al. Lancet Infect Dis. 2008 Feb;8(2):125-32. doi: 10.1016/S1473-3099(08)70017-3. Lancet Infect Dis. 2008. PMID: 18222163 Review. - Limited spread of penicillin-nonsusceptible pneumococci, Skåne County, Sweden.
Melander E, Hansson HB, Mölstad S, Persson K, Ringberg H. Melander E, et al. Emerg Infect Dis. 2004 Jun;10(6):1082-7. doi: 10.3201/eid1006.030488. Emerg Infect Dis. 2004. PMID: 15207061 Free PMC article. - Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics.
Melander E, Ekdahl K, Jönsson G, Mölstad S. Melander E, et al. Pediatr Infect Dis J. 2000 Dec;19(12):1172-7. doi: 10.1097/00006454-200012000-00011. Pediatr Infect Dis J. 2000. PMID: 11144379 - Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci.
Kristinsson KG. Kristinsson KG. Microb Drug Resist. 1997 Summer;3(2):117-23. doi: 10.1089/mdr.1997.3.117. Microb Drug Resist. 1997. PMID: 9185137 Review.
Cited by
- Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007.
Sabuncu E, David J, Bernède-Bauduin C, Pépin S, Leroy M, Boëlle PY, Watier L, Guillemot D. Sabuncu E, et al. PLoS Med. 2009 Jun 2;6(6):e1000084. doi: 10.1371/journal.pmed.1000084. Epub 2009 Jun 2. PLoS Med. 2009. PMID: 19492093 Free PMC article. - Trends in antibiotic prescribing for adults in the United States--1995 to 2002.
Roumie CL, Halasa NB, Grijalva CG, Edwards KM, Zhu Y, Dittus RS, Griffin MR. Roumie CL, et al. J Gen Intern Med. 2005 Aug;20(8):697-702. doi: 10.1111/j.1525-1497.2005.0148.x. J Gen Intern Med. 2005. PMID: 16050877 Free PMC article. - The impact of an intensive antimicrobial control program in a Taiwanese medical center.
Chang MT, Wu TH, Wang CY, Jang TN, Huang CY. Chang MT, et al. Pharm World Sci. 2006 Aug;28(4):257-64. doi: 10.1007/s11096-006-9035-5. Epub 2006 Oct 26. Pharm World Sci. 2006. PMID: 17066241 Clinical Trial. - Impact of Gram stain results on initial treatment selection in patients with ventilator-associated pneumonia: a retrospective analysis of two treatment algorithms.
Yoshimura J, Kinoshita T, Yamakawa K, Matsushima A, Nakamoto N, Hamasaki T, Fujimi S. Yoshimura J, et al. Crit Care. 2017 Jun 19;21(1):156. doi: 10.1186/s13054-017-1747-5. Crit Care. 2017. PMID: 28625166 Free PMC article. - Impact of national interventions to promote responsible antibiotic use: a systematic review.
Lim JM, Singh SR, Duong MC, Legido-Quigley H, Hsu LY, Tam CC. Lim JM, et al. J Antimicrob Chemother. 2020 Jan 1;75(1):14-29. doi: 10.1093/jac/dkz348. J Antimicrob Chemother. 2020. PMID: 31834401 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials